Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaoutar Hafraoui

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Revue Medicale De Liege|February 15, 2024
[How I manage polycythemia]Gérôme Lombardo, Kaoutar Hafraoui, Yves Beguin, et al.
Haematologica|September 13, 2005
Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantationGaëtan Vanstraelen, Frédéric Baron, Pascale Frère, et al.
European Journal of Internal Medicine|April 28, 2009
Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosisKaoutar Hafraoui, Michel Moutschen, Julie Smet, et al.
European Journal of Haematology|December 5, 2013
Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomideJo Caers, Kaoutar Hafraoui, Aurore Keutgens, et al.
Blood|May 23, 2014
Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trialAurélie Jaspers, Frédéric Baron, Evelyne Willems, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 2, 2025
Whipple's disease presenting with bone marrow findings mimicking prefibrotic myelofibrosis: A diagnostic pitfallGaëlle Vertenoeil, Kaoutar Hafraoui, Patrick Collins, et al.
Experimental Hematology|June 27, 2006
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor responseGaëtan Vanstraelen, Frédéric Baron, Evelyne Willems, et al.
Acta Clinica Belgica|April 15, 2016
Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation in two patients with multiple myelomaCéline Gregoire, Julien Guiot, Gaëlle Vertenoeil, et al.
American Journal of Hematology|June 27, 2015
Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survivalAurélie Jaspers, Frédéric Baron, Sophie Servais, et al.
American Journal of Hematology|March 25, 2015
Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantationAurélie Jaspers, Frédéric Baron, Johan Maertens, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Revue Medicale De Liege|February 15, 2024
[How I manage polycythemia]Gérôme Lombardo, Kaoutar Hafraoui, Yves Beguin, et al.
Haematologica|September 13, 2005
Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantationGaëtan Vanstraelen, Frédéric Baron, Pascale Frère, et al.
European Journal of Internal Medicine|April 28, 2009
Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosisKaoutar Hafraoui, Michel Moutschen, Julie Smet, et al.
European Journal of Haematology|December 5, 2013
Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomideJo Caers, Kaoutar Hafraoui, Aurore Keutgens, et al.
Blood|May 23, 2014
Erythropoietin therapy after allogeneic hematopoietic cell transplantation: a prospective, randomized trialAurélie Jaspers, Frédéric Baron, Evelyne Willems, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 2, 2025
Whipple's disease presenting with bone marrow findings mimicking prefibrotic myelofibrosis: A diagnostic pitfallGaëlle Vertenoeil, Kaoutar Hafraoui, Patrick Collins, et al.
Experimental Hematology|June 27, 2006
Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor responseGaëtan Vanstraelen, Frédéric Baron, Evelyne Willems, et al.
Acta Clinica Belgica|April 15, 2016
Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation in two patients with multiple myelomaCéline Gregoire, Julien Guiot, Gaëlle Vertenoeil, et al.
American Journal of Hematology|June 27, 2015
Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survivalAurélie Jaspers, Frédéric Baron, Sophie Servais, et al.
American Journal of Hematology|March 25, 2015
Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantationAurélie Jaspers, Frédéric Baron, Johan Maertens, et al.
Pageof 2